- 2023-2024 EMBRACE MBC Virtual Forum Series
- ASCO® GU 2024
- ASCO® 2023
- COVID-19
- Leukemia
- Lymphoma
- Myeloma
- MDS and MPN
- Breast
- Lung
- Gynecologic
- Genitourinary
- Gastrointestinal
- Colorectal
- Basic Science
- Supportive and Palliative Care
- CNS
- Skin
- Head and Neck
- Business
Playback speed
10 seconds
Study of Ribociclib and PDR001 in HR+ Metastatic Breast Cancer
By
Dana-Farber Cancer Institute
FEATURING
Sara Tolaney
By
Dana-Farber Cancer Institute
FEATURING
Sara Tolaney
1,818 views
September 24, 2019
Login to view comments.
Click here to Login
Breast